ACBD5 antibody
Principal name
ACBD5 antibody
Alternative names for ACBD5 antibody
KIAA1996, Acyl-CoA-binding domain-containing protein 5
Ncbi ID
9606, NP_663736, NP_001035938, NP_001035938.1, NM_001102436, NM_001102437, NM_001102438, NM_001077635, NM_145698
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB)
Background of ACBD5 antibody
- Kit Component:
- - KN207033G1, ACBD5 gRNA vector 1 in pCas-Guide vector
- KN207033G2, ACBD5 gRNA vector 2 in pCas-Guide vector
- KN207033D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Western Blot analysis of ACBD5 expression in transfected 293T cell line (H00091452-T01) by ACBD5 MaxPab polyclonal antibody.Lane 1: ACBD5 transfected lysate(53.9 KDa).Lane 2: Non-transfected lysate.
Human Brain; WB Suggested Anti-ACBD5 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: Human brain; ACBD5 antibody - N-terminal region (ARP44943_P050) in Human Brain cells using Western Blot
Human Brain; WB Suggested Anti-ACBD5 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: Human brain; ACBD5 antibody - C-terminal region (ARP44945_P050) in Human Brain cells using Western Blot
WB Suggested Anti-ACBD5 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 62500; Positive Control: Human brain
WB Suggested Anti-ACBD5 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 62500; Positive Control: Human brain
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA335955 | ACBD5 antibody |
||||||
| Rabbit Polyclonal Anti-ACBD5 Antibody | |||||||
 |
Rabbit | IgG | Purified | Bov, Can, Eq, Hu, Ms, Por, Rb, Rt | WB |
50 µg /
€325.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA335956 | ACBD5 antibody |
||||||
| Rabbit Polyclonal Anti-ACBD5 Antibody | |||||||
 |
Rabbit | IgG | Purified | Bov, Can, Eq, Hu, Ms, Por, Rb, Rt | WB |
50 µg /
€325.00
|
|
| OriGene Technologies, Inc. | |||||||
CRISPR
| Catalog No. | Species | Donor Vector | |
|---|---|---|---|
| KN207033 | ACBD5 - human gene knockout kit via CRISPR |
||
 |
Human | GFP-Puro |
1 kit /
€1,200.00
|
| OriGene Technologies, Inc. | |||
| KN207033BN | ACBD5 - human gene knockout kit via CRISPR |
||
|
Human | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN207033LP | ACBD5 - human gene knockout kit via CRISPR |
||
|
Human | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN207033RB | ACBD5 - human gene knockout kit via CRISPR |
||
|
Human | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP307033 | ACBD5 (transcript variant 2) |
||||
| Recombinant protein of human acyl-Coenzyme A binding domain containing 5 (ACBD5), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€680.00
|
|
| OriGene Technologies, Inc. | |||||
| TP312795 | ACBD5 (transcript variant 1) |
||||
| Recombinant protein of human acyl-Coenzyme A binding domain containing 5 (ACBD5), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€680.00
|
|
| OriGene Technologies, Inc. | |||||
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC212795L2V | Lenti ORF particles, ACBD5 (mGFP-tagged) - Human acyl-CoA binding domain containing 5 (ACBD5), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,050.00
|
|
| OriGene Technologies, Inc. | ||
| RC212795L1V | Lenti ORF particles, ACBD5 (Myc-DDK tagged) - Human acyl-CoA binding domain containing 5 (ACBD5), transcript variant 1 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€940.00
|
|
| OriGene Technologies, Inc. | ||
| RC229268L1V | Lenti ORF particles, ACBD5 (Myc-DDK tagged) - Human acyl-CoA binding domain containing 5 (ACBD5), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€940.00
|
|
| OriGene Technologies, Inc. | ||
Mouse Lenti ORF Particles
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR211464L2V | Lenti ORF particles, Acbd5 (GFP-tagged ORF) - Rat acyl-Coenzyme A binding domain containing 5 (Acbd5), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,080.00
|
|
| OriGene Technologies, Inc. | ||
| RR211464L1V | Lenti ORF particles, Acbd5 (Myc-DDK-tagged ORF) - Rat acyl-Coenzyme A binding domain containing 5 (Acbd5), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€966.00
|
|
| OriGene Technologies, Inc. | ||
